♥
ISIN : INE0I3401014
NSE : DBOL
Face Value : 10
Industry : Unspecified
EPS : 7.00
EPS (TTM) : 5.12
Price to Earning (P/E) : 9.44
Book Value : 152.35
Price to Bookvalue (P/B) : 0.43
Dividend Yield : 4 %
Return on Equity (ROE) : 4.65 %
Return on Capital Employed (ROCE) : 5.76 %
Dhampur Bio Organics Limited
ISIN : INE0I3401014
NSE : DBOL
Face Value : 10
Industry : Unspecified
EPS : 7.00
EPS (TTM) : 5.12
Price to Earning (P/E) : 9.44
Book Value : 152.35
Price to Bookvalue (P/B) : 0.43
Dividend Yield : 4 %
Return on Equity (ROE) : 4.65 %
Return on Capital Employed (ROCE) : 5.76 %
Dhampur Bio share price(28-Mar-2025) | |
|---|---|
| Open / Close | 67 - 66.08 -1.4 % |
| Low / High | 66.08 - 67 1.4 % |
| Trade Volume | 53,135 |
| 52 Week Low / High | 0 - 0 NAN % |
-
YOU MAY ALSO LIKE
- CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator - Stock market course tutorial
Stock Market Investment Course explained in simple words. - Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE - High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE - How much money do you need to retire
Know how much money do you need to retire, before how much to invest ? - Share Market basics for beginners
Share Market jargons in simple terms
CONSOLIDATED QUARTERLY RESULT FOR DHAMPUR BIO ORGANICS LIMITED
| Date End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 5416.3 | 6961.06 | 9210.1 | 7094.5 | 6655.7 | 4247.8 | 5946.2 | 6378.4 |
| Total Income | 5478.2 | 6970.81 | 9227.5 | 7118 | 6661.9 | 4406.4 | 5996.6 | 6386.2 |
| Total Expenditure | 5192.6 | 6618.17 | 8048.2 | 6689.1 | 6464.1 | 4292.1 | 5134.6 | 6049 |
| Other Income | 61.9 | 9.75 | 17.4 | 23.5 | 6.2 | 158.6 | 50.4 | 7.8 |
| Operating Profit | 285.6 | 352.64 | 1179.3 | 428.9 | 197.8 | 114.3 | 862 | 337.2 |
| Interest | 91.2 | 48.65 | 125.3 | 133.2 | 88.1 | 56.5 | 175.5 | 211.1 |
| PBDT | 194.4 | 303.99 | 1054 | 295.7 | 109.7 | 57.8 | 686.5 | 126.1 |
| Depreciation | 87.4 | 102.24 | 131.1 | 110.8 | 104.9 | 136.2 | 142.9 | 118.9 |
| Profit Before Tax | 107 | 201.75 | 922.9 | 184.9 | 4.8 | -78.4 | 543.6 | 7.2 |
| Tax | 29.8 | 52.14 | 120.9 | 58.3 | 4.2 | -22 | 149.5 | 6 |
| Profit After Tax | 77.2 | 149.61 | 802 | 126.6 | 0.6 | -56.4 | 394.1 | 1.2 |
| Net Profit | 77.2 | 149.61 | 802 | 126.6 | 0.6 | -56.4 | 394.1 | 1.2 |
| Equity Capital | 663.88 | 663.88 | 663.88 | 663.88 | 663.88 | 663.88 | 663.88 | 663.88 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | 1.16 | 2.25 | 12.08 | 1.91 | 0.01 | -0.85 | 5.94 | 0.02 |
| Diluted Eps After Extraordinary Items | 1.16 | 2.25 | 12.08 | 1.91 | 0.01 | -0.85 | 5.94 | 0.02 |
| Diluted Eps Before Extraordinary Items | 1.16 | 2.25 | 12.08 | 1.91 | 0.01 | -0.85 | 5.94 | 0.02 |
STANDALONE QUARTERLY RESULT FOR DHAMPUR BIO ORGANICS LIMITED
| Date End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 5416.3 | 6937.94 | 9174.8 | 6762.6 | 6655 | 4247.8 | 5946.2 | 6378.4 |
| Total Income | 5464.3 | 6942.47 | 9193.9 | 6787.8 | 6658.7 | 4407.9 | 5994.4 | 6385.7 |
| Total Expenditure | 5182.8 | 6602.35 | 8037.8 | 6376.4 | 6453.6 | 4279 | 5123.8 | 6038.9 |
| Other Income | 48 | 4.53 | 19.1 | 25.2 | 3.7 | 160.1 | 48.2 | 7.3 |
| Operating Profit | 281.5 | 340.12 | 1156.1 | 411.4 | 205.1 | 128.9 | 870.6 | 346.8 |
| Interest | 91 | 48.54 | 124.6 | 132.8 | 88 | 56.4 | 175.5 | 211.1 |
| Exceptional Items | 39.3 | |||||||
| PBDT | 190.5 | 291.58 | 1070.8 | 278.6 | 117.1 | 72.5 | 695.1 | 135.7 |
| Depreciation | 87.3 | 102.09 | 129.5 | 110.8 | 104.8 | 136.1 | 142.9 | 118.6 |
| Profit Before Tax | 103.2 | 189.49 | 941.3 | 167.8 | 12.3 | -63.6 | 552.2 | 17.1 |
| Tax | 27.6 | 52.14 | 121.8 | 58.3 | 4.2 | -22 | 140 | 6 |
| Profit After Tax | 75.6 | 137.35 | 819.5 | 109.5 | 8.1 | -41.6 | 412.2 | 11.1 |
| Net Profit | 75.6 | 137.35 | 819.5 | 109.5 | 8.1 | -41.6 | 412.2 | 11.1 |
| Equity Capital | 663.88 | 663.88 | 663.88 | 663.88 | 663.88 | 663.88 | 663.88 | 663.88 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | 1.14 | 2.07 | 12.34 | 1.65 | 0.12 | -0.63 | 6.21 | 0.17 |
| Diluted Eps After Extraordinary Items | 1.14 | 2.07 | 12.34 | 1.65 | 0.12 | -0.63 | 6.21 | 0.17 |
| Diluted Eps Before Extraordinary Items | 1.14 | 2.07 | 12.34 | 1.65 | 0.12 | -0.63 | 6.21 | 0.17 |
CONSOLIDATED ANNUAL RESULT FOR DHAMPUR BIO ORGANICS LIMITED
| Date End | Mar 2023 | Mar 2024 |
|---|---|---|
| No of months | 12 months | 12 months |
| Net Sales | 26544.4 | 23944.2 |
| Total Income | 26658.6 | 24182.9 |
| Total Expenditure | 24497.2 | 22579.9 |
| Other Income | 114.2 | 238.7 |
| Operating Profit | 2161.4 | 1603 |
| Interest | 408.4 | 453.3 |
| PBDT | 1753 | 1149.7 |
| Depreciation | 405.3 | 494.8 |
| Profit Before Tax | 1347.7 | 654.9 |
| Tax | 236.7 | 190 |
| Profit After Tax | 1111 | 464.9 |
| Net Profit | 1111 | 464.9 |
| Equity Capital | 663.88 | 663.88 |
| Face Value (IN RS) | 10 | 10 |
| Reserves | 9223.4 | 9450.8 |
| Calculated EPS | 16.74 | 7 |
| Diluted Eps After Extraordinary Items | 16.74 | 7 |
| Diluted Eps Before Extraordinary Items | 16.74 | 7 |
STANDALONE ANNUAL RESULT FOR DHAMPUR BIO ORGANICS LIMITED
| Date End | Mar 2023 | Mar 2024 |
|---|---|---|
| No of months | 12 months | 12 months |
| Net Sales | 26486 | 23611.6 |
| Total Income | 26582.2 | 23848.8 |
| Total Expenditure | 24453.1 | 22232.8 |
| Other Income | 96.2 | 237.2 |
| Operating Profit | 2129.1 | 1616 |
| Interest | 407.4 | 452.7 |
| Exceptional Items | 39.3 | |
| PBDT | 1761 | 1163.3 |
| Depreciation | 403.2 | 494.6 |
| Profit Before Tax | 1357.8 | 668.7 |
| Tax | 237.6 | 180.5 |
| Profit After Tax | 1120.2 | 488.2 |
| Net Profit | 1120.2 | 488.2 |
| Equity Capital | 663.88 | 663.88 |
| Face Value (IN RS) | 10 | 10 |
| Reserves | 9293.2 | 9542.7 |
| Calculated EPS | 16.87 | 7.35 |
| Diluted Eps After Extraordinary Items | 16.87 | 7.35 |
| Diluted Eps Before Extraordinary Items | 16.87 | 7.35 |
CONSOLIDATED PROFIT / LOSS FOR DHAMPUR BIO ORGANICS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 5 months | 12 months | 12 months | 12 months |
| Gross Sales | 0 | 1540.9 Cr | 2654.44 Cr | 2394.42 Cr |
| Sales | 0 | 1526.86 Cr | 2613.53 Cr | 2369.4 Cr |
| Less: Excise Duty | 0 | 0 | 246.91 Cr | 529.98 Cr |
| Net Sales | 0 | 1540.9 Cr | 2407.53 Cr | 1864.44 Cr |
| Increase/Decrease in Stock | 0 | -310.99 Cr | 243.95 Cr | -264.45 Cr |
| Raw Material Consumed | 0 | 1442.58 Cr | 1592.15 Cr | 1635.11 Cr |
| Opening Raw Materials | 0 | 13.06 Cr | 1.02 Cr | 80 Lk |
| Purchases Raw Materials | 0 | 1465.12 Cr | 1588.03 Cr | 1604.56 Cr |
| Closing Raw Materials | 0 | 43.51 Cr | 80 Lk | 1.22 Cr |
| Other Direct Purchases / Brought in cost | 0 | 7.91 Cr | 3.9 Cr | 30.97 Cr |
| Power & Fuel Cost | 0 | 3.11 Cr | 5.48 Cr | 8.85 Cr |
| Electricity & Power | 0 | 3.11 Cr | 5.48 Cr | 8.85 Cr |
| Employee Cost | 0 | 73.63 Cr | 108.02 Cr | 96.66 Cr |
| Salaries, Wages & Bonus | 0 | 65.91 Cr | 98.94 Cr | 87.01 Cr |
| Contributions to EPF & Pension Funds | 0 | 5.6 Cr | 6.83 Cr | 6.96 Cr |
| Workmen and Staff Welfare Expenses | 0 | 56 Lk | 73 Lk | 67 Lk |
| Other Manufacturing Expenses | 0 | 97.59 Cr | 128.22 Cr | 141.05 Cr |
| Processing Charges | 0 | 0 | 0 | 4.5 Cr |
| Repairs and Maintenance | 0 | 40.17 Cr | 35.34 Cr | 34.49 Cr |
| Packing Material Consumed | 0 | 21 Cr | 33.78 Cr | 47.85 Cr |
| General and Administration Expenses | 1 Lk | 21.84 Cr | 39.26 Cr | 50.31 Cr |
| Rent , Rates & Taxes | 1 Lk | 2.21 Cr | 15.42 Cr | 16.76 Cr |
| Insurance | 0 | 3.1 Cr | 4.08 Cr | 4.72 Cr |
| Professional and legal fees | 0 | 3.48 Cr | 5.9 Cr | 15.18 Cr |
| Traveling and conveyance | 0 | 4.83 Cr | 7.64 Cr | 8 Cr |
| Selling and Distribution Expenses | 0 | 19.95 Cr | 84.04 Cr | 43.69 Cr |
| Sales Commissions & Incentives | 0 | 2.87 Cr | 3.64 Cr | 2.59 Cr |
| Freight and Forwarding | 0 | 0 | 0 | 41.1 Cr |
| Miscellaneous Expenses | 0 | 10.49 Cr | 15.1 Cr | 19.21 Cr |
| Provision for doubtful debts | 0 | 0 | 80 Lk | 70 Lk |
| Loss on disposal of fixed assets(net) | 0 | 19 Lk | 2 Lk | 3.54 Cr |
| Loss on foreign exchange fluctuations | 0 | 5 Lk | 72 Lk | 1 Lk |
| Less: Expenses Capitalised | 0 | 0 | 13.41 Cr | 2.42 Cr |
| Total Expenditure | 1 Lk | 1358.2 Cr | 2202.81 Cr | 1728.01 Cr |
| Other Income | 0 | 7.69 Cr | 11.42 Cr | 23.87 Cr |
| Interest Received | 0 | 52 Lk | 48 Lk | 2.31 Cr |
| Profit on sale of Fixed Assets | 0 | 1.86 Cr | 5 Lk | 17.33 Cr |
| Provision Written Back | 0 | 22 Lk | 6.77 Cr | 1.9 Cr |
| Foreign Exchange Gains | 0 | 4 Lk | 0 | 1.42 Cr |
| Operating Profit | -1 Lk | 190.39 Cr | 216.14 Cr | 160.3 Cr |
| Interest | 0 | 30.13 Cr | 40.84 Cr | 45.33 Cr |
| Bank Charges etc | 0 | 0 | 2.76 Cr | 1.97 Cr |
| PBDT | -1 Lk | 160.26 Cr | 175.3 Cr | 114.97 Cr |
| Depreciation | 0 | 31.29 Cr | 40.53 Cr | 49.48 Cr |
| Profit Before Taxation & Exceptional Items | -1 Lk | 128.97 Cr | 134.77 Cr | 65.49 Cr |
| Profit Before Tax | -1 Lk | 128.97 Cr | 134.77 Cr | 65.49 Cr |
| Provision for Tax | 0 | 27.08 Cr | 23.67 Cr | 19 Cr |
| Current Income Tax | 0 | 23.29 Cr | 22.43 Cr | 11.65 Cr |
| Deferred Tax | 0 | 3.79 Cr | 1.24 Cr | 7.91 Cr |
| Profit After Tax | -1 Lk | 101.89 Cr | 111.1 Cr | 46.49 Cr |
| Consolidated Net Profit | -1 Lk | 101.89 Cr | 111.1 Cr | 46.49 Cr |
| Profit Balance B/F | 0 | -1 Lk | 102 Cr | 213.1 Cr |
| Appropriations | -1 Lk | 101.88 Cr | 213.1 Cr | 259.59 Cr |
| Other Appropriation | 0 | 32 Lk | 0 | 23.23 Cr |
| Equity Dividend % | 0 | 0 | 35 | 25 |
| Earnings Per Share | -0 | 15.35 | 16.73 | 7 |
| Adjusted EPS | -0 | 15.35 | 16.73 | 7 |
STANDALONE PROFIT / LOSS FOR DHAMPUR BIO ORGANICS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 5 months | 12 months | 12 months | 12 months |
| Gross Sales | 0 | 1540.9 Cr | 2648.6 Cr | 2361.16 Cr |
| Sales | 0 | 1526.86 Cr | 2607.7 Cr | 2336.14 Cr |
| Less: Excise Duty | 0 | 0 | 246.91 Cr | 529.98 Cr |
| Net Sales | 0 | 1540.9 Cr | 2401.69 Cr | 1831.18 Cr |
| Increase/Decrease in Stock | 0 | -310.99 Cr | 243.95 Cr | -264.45 Cr |
| Raw Material Consumed | 0 | 1442.58 Cr | 1592.15 Cr | 1606.01 Cr |
| Opening Raw Materials | 0 | 13.06 Cr | 1.02 Cr | 80 Lk |
| Purchases Raw Materials | 0 | 1465.12 Cr | 1588.03 Cr | 1604.56 Cr |
| Closing Raw Materials | 0 | 43.51 Cr | 80 Lk | 1.22 Cr |
| Other Direct Purchases / Brought in cost | 0 | 7.91 Cr | 3.9 Cr | 1.87 Cr |
| Power & Fuel Cost | 0 | 3.09 Cr | 5.47 Cr | 8.83 Cr |
| Electricity & Power | 0 | 3.09 Cr | 5.47 Cr | 8.83 Cr |
| Employee Cost | 0 | 71.58 Cr | 105.46 Cr | 93.94 Cr |
| Salaries, Wages & Bonus | 0 | 64.04 Cr | 96.49 Cr | 84.4 Cr |
| Contributions to EPF & Pension Funds | 0 | 5.51 Cr | 6.75 Cr | 6.88 Cr |
| Workmen and Staff Welfare Expenses | 0 | 47 Lk | 70 Lk | 64 Lk |
| Other Manufacturing Expenses | 0 | 97.54 Cr | 128.16 Cr | 140.98 Cr |
| Processing Charges | 0 | 0 | 0 | 4.5 Cr |
| Repairs and Maintenance | 0 | 40.12 Cr | 35.28 Cr | 34.42 Cr |
| Packing Material Consumed | 0 | 21 Cr | 33.78 Cr | 47.85 Cr |
| General and Administration Expenses | 0 | 19.59 Cr | 38.88 Cr | 49.8 Cr |
| Rent , Rates & Taxes | 0 | 2.21 Cr | 15.42 Cr | 16.76 Cr |
| Insurance | 0 | 3.1 Cr | 4.08 Cr | 4.72 Cr |
| Professional and legal fees | 0 | 3.35 Cr | 5.86 Cr | 15.13 Cr |
| Traveling and conveyance | 0 | 4.22 Cr | 7.3 Cr | 7.68 Cr |
| Selling and Distribution Expenses | 0 | 19.95 Cr | 84.04 Cr | 43.26 Cr |
| Sales Commissions & Incentives | 0 | 2.87 Cr | 3.64 Cr | 2.58 Cr |
| Miscellaneous Expenses | 1 Lk | 10.59 Cr | 13.7 Cr | 17.35 Cr |
| Provision for doubtful debts | 0 | 0 | 80 Lk | 70 Lk |
| Loss on disposal of fixed assets(net) | 0 | 0 | 2 Lk | 3.54 Cr |
| Loss on foreign exchange fluctuations | 0 | 0 | 68 Lk | 0 |
| Less: Expenses Capitalised | 0 | 0 | 13.41 Cr | 2.42 Cr |
| Total Expenditure | 1 Lk | 1353.93 Cr | 2198.4 Cr | 1693.3 Cr |
| Other Income | 0 | 7.23 Cr | 9.62 Cr | 23.72 Cr |
| Interest Received | 0 | 21 Lk | 36 Lk | 1.33 Cr |
| Profit on sale of Fixed Assets | 0 | 1.86 Cr | 5 Lk | 17.33 Cr |
| Provision Written Back | 0 | 22 Lk | 6.99 Cr | 1.9 Cr |
| Foreign Exchange Gains | 0 | 4 Lk | 0 | 1.42 Cr |
| Operating Profit | -1 Lk | 194.2 Cr | 212.91 Cr | 161.6 Cr |
| Interest | 0 | 30.1 Cr | 40.74 Cr | 45.27 Cr |
| Bank Charges etc | 0 | 0 | 2.66 Cr | 1.91 Cr |
| PBDT | -1 Lk | 164.1 Cr | 172.17 Cr | 116.33 Cr |
| Depreciation | 0 | 30.79 Cr | 40.32 Cr | 49.46 Cr |
| Profit Before Taxation & Exceptional Items | -1 Lk | 133.31 Cr | 131.85 Cr | 66.87 Cr |
| Exceptional Income / Expenses | 0 | -4.01 Cr | 3.93 Cr | 0 |
| Profit Before Tax | -1 Lk | 129.3 Cr | 135.78 Cr | 66.87 Cr |
| Provision for Tax | 0 | 25.69 Cr | 23.76 Cr | 18.05 Cr |
| Current Income Tax | 0 | 23.29 Cr | 22.43 Cr | 11.65 Cr |
| Deferred Tax | 0 | 2.4 Cr | 1.33 Cr | 6.96 Cr |
| Profit After Tax | -1 Lk | 103.61 Cr | 112.02 Cr | 48.82 Cr |
| Consolidated Net Profit | -1 Lk | 103.61 Cr | 112.02 Cr | 48.82 Cr |
| Profit Balance B/F | 0 | -1 Lk | 103.87 Cr | 215.89 Cr |
| Appropriations | -1 Lk | 103.6 Cr | 215.89 Cr | 264.71 Cr |
| Other Appropriation | 0 | 17 Lk | 0 | 23.24 Cr |
| Equity Dividend % | 0 | 0 | 35 | 25 |
| Earnings Per Share | -0 | 15.61 | 16.87 | 7.35 |
| Adjusted EPS | -0 | 15.61 | 16.87 | 7.35 |
CONSOLIDATED CASH FLOW FOR DHAMPUR BIO ORGANICS LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 5 months | 12 months | 12 months | 12 months |
| Profit Before Tax | -1 Lk | 128.97 Cr | 134.77 Cr | 65.49 Cr |
| Adjustment | 0 | 60.49 Cr | 76.26 Cr | 77.77 Cr |
| Changes In working Capital | 0 | -413.37 Cr | 179.71 Cr | -227.07 Cr |
| Cash Flow after changes in Working Capital | -1 Lk | -223.91 Cr | 390.74 Cr | -83.81 Cr |
| Cash Flow from Operating Activities | -1 Lk | -246.47 Cr | 368.11 Cr | -101.33 Cr |
| Cash Flow from Investing Activities | 0 | -138.29 Cr | -208.91 Cr | -166.29 Cr |
| Cash Flow from Financing Activitie | 1 Lk | 393.87 Cr | -78.12 Cr | 169.56 Cr |
| Net Cash Inflow / Outflow | 0 | 9.11 Cr | 81.08 Cr | -98.06 Cr |
| Opening Cash & Cash Equivalents | 0 | 13.87 Cr | 22.97 Cr | 104.05 Cr |
| Closing Cash & Cash Equivalent | 0 | 22.98 Cr | 104.05 Cr | 5.99 Cr |
STANDALONE CASH FLOW FOR DHAMPUR BIO ORGANICS LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 5 months | 12 months | 12 months | 12 months |
| Profit Before Tax | -1 Lk | 133.31 Cr | 131.85 Cr | 66.87 Cr |
| Adjustment | 0 | 59.71 Cr | 74.83 Cr | 77.86 Cr |
| Changes In working Capital | 0 | -403.17 Cr | 202.17 Cr | -249.4 Cr |
| Cash Flow after changes in Working Capital | -1 Lk | -210.15 Cr | 408.85 Cr | -104.67 Cr |
| Cash Flow from Operating Activities | -1 Lk | -232.71 Cr | 386.22 Cr | -122.19 Cr |
| Cash Flow from Investing Activities | 0 | -143.6 Cr | -228.24 Cr | -143.48 Cr |
| Cash Flow from Financing Activitie | 1 Lk | 394.18 Cr | -78.12 Cr | 169.64 Cr |
| Net Cash Inflow / Outflow | 0 | 17.87 Cr | 79.86 Cr | -96.03 Cr |
| Opening Cash & Cash Equivalents | 0 | 68 Lk | 18.55 Cr | 98.41 Cr |
| Closing Cash & Cash Equivalent | 0 | 18.55 Cr | 98.41 Cr | 2.38 Cr |
CONSOLIDATED BALANCE SHEET FOR DHAMPUR BIO ORGANICS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 66.39 Cr | 66.39 Cr | 66.39 Cr | 66.39 Cr |
| Equity - Authorised | 91.6 Cr | 91.6 Cr | 91.6 Cr | 91.6 Cr |
| Equity - Issued | 66.39 Cr | 66.39 Cr | 66.39 Cr | 66.39 Cr |
| Equity Paid Up | 66.39 Cr | 66.39 Cr | 66.39 Cr | 66.39 Cr |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | 708.56 Cr | 811.06 Cr | 922.34 Cr | 945.08 Cr |
| Capital Reserves | 708.41 Cr | 708.41 Cr | 708.41 Cr | 708.41 Cr |
| Profit & Loss Account Balance | -1 Lk | 101.56 Cr | 213.1 Cr | 236.36 Cr |
| Reserve excluding Revaluation Reserve | 708.56 Cr | 811.06 Cr | 922.34 Cr | 945.08 Cr |
| Shareholder's Funds | 774.95 Cr | 877.45 Cr | 988.73 Cr | 1011.47 Cr |
| Secured Loans | 99.19 Cr | 104.83 Cr | 168.72 Cr | 176.95 Cr |
| Term Loans - Banks | 99.19 Cr | 104.83 Cr | 168.72 Cr | 176.95 Cr |
| Deferred Tax Assets / Liabilities | 30.73 Cr | 34.55 Cr | 34.9 Cr | 42.5 Cr |
| Deferred Tax Assets | 69.1 Cr | 56.17 Cr | 54.47 Cr | 56.86 Cr |
| Deferred Tax Liability | 99.83 Cr | 90.72 Cr | 89.37 Cr | 99.36 Cr |
| Other Long Term Liabilities | 11.18 Cr | 9.72 Cr | 4.82 Cr | 6.67 Cr |
| Long Term Provisions | 17.36 Cr | 17.53 Cr | 21.33 Cr | 23.22 Cr |
| Total Non-Current Liabilities | 158.46 Cr | 166.63 Cr | 229.77 Cr | 249.34 Cr |
| Trade Payables | 297.87 Cr | 168.67 Cr | 163.89 Cr | 137.23 Cr |
| Sundry Creditors | 297.87 Cr | 168.67 Cr | 163.89 Cr | 137.23 Cr |
| Other Current Liabilities | 51.71 Cr | 125.18 Cr | 133.3 Cr | 105.19 Cr |
| Advances received from customers | 1.4 Cr | 17.88 Cr | 10.58 Cr | 12.11 Cr |
| Interest Accrued But Not Due | 24 Lk | 24 Lk | 29 Lk | 42 Lk |
| Short Term Borrowings | 267 Cr | 659.5 Cr | 557.38 Cr | 805.77 Cr |
| Secured ST Loans repayable on Demands | 267 Cr | 659.5 Cr | 507.38 Cr | 805.77 Cr |
| Working Capital Loans- Sec | 0 | 0 | 507.38 Cr | 805.77 Cr |
| Short Term Provisions | 1.15 Cr | 25.67 Cr | 26.83 Cr | 15.46 Cr |
| Provision for Tax | 0 | 23.29 Cr | 23.31 Cr | 11.65 Cr |
| Total Current Liabilities | 617.73 Cr | 979.02 Cr | 881.4 Cr | 1063.65 Cr |
| Total Liabilities | 1551.14 Cr | 2023.1 Cr | 2099.9 Cr | 2324.46 Cr |
| Gross Block | 1096.83 Cr | 1146.16 Cr | 1399.24 Cr | 1559.75 Cr |
| Less: Accumulated Depreciation | 466.17 Cr | 455.66 Cr | 489.92 Cr | 523.3 Cr |
| Net Block | 630.66 Cr | 690.5 Cr | 909.32 Cr | 1036.45 Cr |
| Capital Work in Progress | 6.99 Cr | 77.9 Cr | 36.17 Cr | 12.95 Cr |
| Non Current Investments | 19 Lk | 0 | 0 | 0 |
| Long Term Investment | 19 Lk | 0 | 0 | 0 |
| Quoted | 19 Lk | 0 | 0 | 0 |
| Long Term Loans & Advances | 12.73 Cr | 10.19 Cr | 6.15 Cr | 10.92 Cr |
| Other Non Current Assets | 0 | 0 | 95 Lk | 93 Lk |
| Total Non-Current Assets | 650.57 Cr | 778.59 Cr | 952.59 Cr | 1061.25 Cr |
| Inventories | 717.39 Cr | 1056.64 Cr | 819.28 Cr | 1082.55 Cr |
| Raw Materials | 13.06 Cr | 43.51 Cr | 80 Lk | 1.22 Cr |
| Work-in Progress | 5.5 Cr | 5.5 Cr | 25.69 Cr | 15.54 Cr |
| Finished Goods | 678.78 Cr | 989.77 Cr | 767.91 Cr | 1042.61 Cr |
| Stores and Spare | 19.99 Cr | 17.81 Cr | 24.62 Cr | 23.04 Cr |
| Sundry Debtors | 106.56 Cr | 107.51 Cr | 153.67 Cr | 87.53 Cr |
| Debtors more than Six months | 0 | 1.19 Cr | 1.88 Cr | 2.61 Cr |
| Debtors Others | 106.56 Cr | 106.38 Cr | 152.65 Cr | 86.48 Cr |
| Cash and Bank | 14.68 Cr | 25.01 Cr | 107.46 Cr | 33.47 Cr |
| Cash in hand | 43 Lk | 55 Lk | 51 Lk | 58 Lk |
| Balances at Bank | 14.25 Cr | 8.88 Cr | 106.95 Cr | 32.89 Cr |
| Other Current Assets | 51.32 Cr | 29.1 Cr | 20.85 Cr | 23.83 Cr |
| Interest accrued and or due on loans | 2 Lk | 8 Lk | 23 Lk | 36 Lk |
| Prepaid Expenses | 3.55 Cr | 25.98 Cr | 3.65 Cr | 4.1 Cr |
| Short Term Loans and Advances | 10.62 Cr | 26.25 Cr | 46.05 Cr | 35.83 Cr |
| Advances recoverable in cash or in kind | 4.4 Cr | 20.45 Cr | 11.21 Cr | 5.62 Cr |
| Advance income tax and TDS | 0 | 0 | 22.44 Cr | 17.21 Cr |
| Total Current Assets | 900.57 Cr | 1244.51 Cr | 1147.31 Cr | 1263.21 Cr |
| Net Current Assets (Including Current Investments) | 282.84 Cr | 265.49 Cr | 265.91 Cr | 199.56 Cr |
| Total Assets | 1551.14 Cr | 2023.1 Cr | 2099.9 Cr | 2324.46 Cr |
| Contingent Liabilities | 36.72 Cr | 37.93 Cr | 59.78 Cr | 46.69 Cr |
| Total Debt | 395.04 Cr | 822.79 Cr | 803.31 Cr | 1046.81 Cr |
| Book Value | 0 | 0 | 148.93 | 152.35 |
| Adjusted Book Value | 116.73 | 132.17 | 148.93 | 152.35 |
STANDALONE BALANCE SHEET FOR DHAMPUR BIO ORGANICS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 66.39 Cr | 66.39 Cr | 66.39 Cr | 66.39 Cr |
| Equity - Authorised | 91.6 Cr | 91.6 Cr | 91.6 Cr | 91.6 Cr |
| Equity - Issued | 66.39 Cr | 66.39 Cr | 66.39 Cr | 66.39 Cr |
| Equity Paid Up | 66.39 Cr | 66.39 Cr | 66.39 Cr | 66.39 Cr |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | 714.55 Cr | 818.43 Cr | 929.32 Cr | 954.27 Cr |
| Capital Reserves | 714.56 Cr | 714.56 Cr | 714.56 Cr | 714.56 Cr |
| Profit & Loss Account Balance | -1 Lk | 103.43 Cr | 215.89 Cr | 241.47 Cr |
| Reserve excluding Revaluation Reserve | 714.55 Cr | 818.43 Cr | 929.32 Cr | 954.27 Cr |
| Shareholder's Funds | 780.94 Cr | 884.82 Cr | 995.71 Cr | 1020.66 Cr |
| Secured Loans | 99.19 Cr | 104.83 Cr | 168.71 Cr | 176.95 Cr |
| Term Loans - Banks | 99.19 Cr | 104.83 Cr | 168.71 Cr | 176.95 Cr |
| Deferred Tax Assets / Liabilities | 24.58 Cr | 27.01 Cr | 27.73 Cr | 34.38 Cr |
| Deferred Tax Assets | 75.25 Cr | 63.71 Cr | 61.64 Cr | 64.98 Cr |
| Deferred Tax Liability | 99.83 Cr | 90.72 Cr | 89.37 Cr | 99.36 Cr |
| Other Long Term Liabilities | 11.05 Cr | 9.72 Cr | 4.82 Cr | 6.67 Cr |
| Long Term Provisions | 17.36 Cr | 17.53 Cr | 21.33 Cr | 23.22 Cr |
| Total Non-Current Liabilities | 152.18 Cr | 159.09 Cr | 222.59 Cr | 241.22 Cr |
| Trade Payables | 285.95 Cr | 168.62 Cr | 163.88 Cr | 137.23 Cr |
| Sundry Creditors | 285.95 Cr | 168.62 Cr | 163.88 Cr | 137.23 Cr |
| Other Current Liabilities | 51.41 Cr | 125.1 Cr | 133.86 Cr | 104.9 Cr |
| Advances received from customers | 1.27 Cr | 17.88 Cr | 11.6 Cr | 12.11 Cr |
| Interest Accrued But Not Due | 24 Lk | 24 Lk | 29 Lk | 42 Lk |
| Short Term Borrowings | 267 Cr | 659.5 Cr | 557.38 Cr | 805.77 Cr |
| Secured ST Loans repayable on Demands | 267 Cr | 659.5 Cr | 507.38 Cr | 805.77 Cr |
| Working Capital Loans- Sec | 267 Cr | 659.5 Cr | 507.38 Cr | 805.77 Cr |
| Short Term Provisions | 1.15 Cr | 25.67 Cr | 26.82 Cr | 15.46 Cr |
| Provision for Tax | 0 | 23.29 Cr | 23.31 Cr | 11.65 Cr |
| Total Current Liabilities | 605.51 Cr | 978.89 Cr | 881.94 Cr | 1063.36 Cr |
| Total Liabilities | 1538.63 Cr | 2022.8 Cr | 2100.24 Cr | 2325.24 Cr |
| Gross Block | 1093.26 Cr | 1145.33 Cr | 1398.35 Cr | 1558.85 Cr |
| Less: Accumulated Depreciation | 464.78 Cr | 455.03 Cr | 489.08 Cr | 522.44 Cr |
| Net Block | 628.48 Cr | 690.3 Cr | 909.27 Cr | 1036.41 Cr |
| Capital Work in Progress | 6.99 Cr | 77.9 Cr | 36.17 Cr | 12.95 Cr |
| Non Current Investments | 10.63 Cr | 6.62 Cr | 27.21 Cr | 28.16 Cr |
| Long Term Investment | 10.63 Cr | 6.62 Cr | 27.21 Cr | 28.16 Cr |
| Unquoted | 36.93 Cr | 36.93 Cr | 53.59 Cr | 54.54 Cr |
| Long Term Loans & Advances | 12.63 Cr | 10.19 Cr | 6.15 Cr | 10.92 Cr |
| Other Non Current Assets | 0 | 0 | 96 Lk | 93 Lk |
| Total Non-Current Assets | 658.73 Cr | 785.01 Cr | 979.76 Cr | 1089.37 Cr |
| Unquoted | 36.93 Cr | 36.93 Cr | 53.59 Cr | 54.54 Cr |
| Inventories | 717.39 Cr | 1056.64 Cr | 819.29 Cr | 1082.55 Cr |
| Raw Materials | 13.06 Cr | 43.51 Cr | 80 Lk | 1.22 Cr |
| Work-in Progress | 5.5 Cr | 5.5 Cr | 25.69 Cr | 15.54 Cr |
| Finished Goods | 678.78 Cr | 989.77 Cr | 767.91 Cr | 1042.61 Cr |
| Stores and Spare | 19.99 Cr | 17.81 Cr | 24.63 Cr | 23.04 Cr |
| Sundry Debtors | 105.18 Cr | 107.98 Cr | 133.22 Cr | 87.53 Cr |
| Debtors more than Six months | 0 | 1.19 Cr | 1.88 Cr | 2.61 Cr |
| Debtors Others | 105.18 Cr | 106.85 Cr | 132.2 Cr | 86.48 Cr |
| Cash and Bank | 1.49 Cr | 20.58 Cr | 101.82 Cr | 6.46 Cr |
| Cash in hand | 37 Lk | 50 Lk | 45 Lk | 51 Lk |
| Balances at Bank | 1.12 Cr | 4.5 Cr | 101.37 Cr | 5.95 Cr |
| Other Current Assets | 51.32 Cr | 29.1 Cr | 20.85 Cr | 23.78 Cr |
| Interest accrued on Investments | 2 Lk | 8 Lk | 0 | 0 |
| Interest accrued and or due on loans | 0 | 0 | 23 Lk | 36 Lk |
| Prepaid Expenses | 3.55 Cr | 25.98 Cr | 3.65 Cr | 4.1 Cr |
| Short Term Loans and Advances | 4.52 Cr | 23.49 Cr | 45.3 Cr | 35.55 Cr |
| Advances recoverable in cash or in kind | 4.19 Cr | 20.05 Cr | 10.46 Cr | 5.62 Cr |
| Advance income tax and TDS | 0 | 0 | 22.44 Cr | 17.21 Cr |
| Total Current Assets | 879.9 Cr | 1237.79 Cr | 1120.48 Cr | 1235.87 Cr |
| Net Current Assets (Including Current Investments) | 274.39 Cr | 258.9 Cr | 238.54 Cr | 172.51 Cr |
| Total Assets | 1538.63 Cr | 2022.8 Cr | 2100.24 Cr | 2325.24 Cr |
| Contingent Liabilities | 36.72 Cr | 37.93 Cr | 59.78 Cr | 46.69 Cr |
| Total Debt | 394.89 Cr | 822.79 Cr | 803.29 Cr | 1046.81 Cr |
| Book Value | 0 | 0 | 149.98 | 153.74 |
| Adjusted Book Value | 117.63 | 133.28 | 149.98 | 153.74 |
FINANCIAL RATIOS (CONSOLIDATED) FOR DHAMPUR BIO ORGANICS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | -0 | 15.35 | 16.73 | 7 |
| CEPS(Rs) | -0 | 20.06 | 22.84 | 14.46 |
| DPS(Rs) | 0 | 0 | 3.5 | 2.5 |
| Book NAV/Share(Rs) | 116.73 | 132.17 | 148.93 | 152.35 |
| Tax Rate(%) | 0 | 21 | 17.56 | 29.01 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 0 | 11.86 | 7.71 | 5.7 |
| EBIT Margin(%) | 0 | 10.33 | 6.62 | 4.63 |
| Pre Tax Margin(%) | 0 | 8.37 | 5.08 | 2.74 |
| PAT Margin (%) | 0 | 6.61 | 4.19 | 1.94 |
| Cash Profit Margin (%) | 0 | 8.64 | 5.71 | 4.01 |
| Performance Ratios | ||||
| ROA(%) | -0 | 5.7 | 5.39 | 2.1 |
| ROE(%) | -0 | 12.33 | 11.9 | 4.65 |
| ROCE(%) | -0 | 11.09 | 10.04 | 5.76 |
| Asset Turnover(x) | 0 | 0.86 | 1.29 | 1.08 |
| Sales/Fixed Asset(x) | 0 | 1.37 | 2.09 | 1.62 |
| Working Capital/Sales(x) | 0 | 5.8 | 9.98 | 12 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 0 | 0.73 | 0.48 | 0.62 |
| Receivable days | 0 | 25.35 | 17.96 | 18.38 |
| Inventory Days | 0 | 210.11 | 128.98 | 144.96 |
| Payable days | 0 | 75.24 | 33.06 | 40.09 |
| Valuation Parameters | ||||
| PER(x) | 0 | 0 | 8.56 | 16.42 |
| PCE(x) | 0 | 0 | 6.27 | 7.95 |
| Price/Book(x) | 0 | 0 | 0.96 | 0.75 |
| Yield(%) | 0 | 0 | 2.44 | 2.17 |
| EV/Net Sales(x) | 0 | 0.56 | 0.68 | 0.95 |
| EV/Core EBITDA(x) | -44675 | 4.54 | 7.62 | 11.08 |
| EV/EBIT(x) | -44675 | 5.43 | 9.38 | 16.03 |
| EV/CE(x) | 0.29 | 0.43 | 0.78 | 0.86 |
| M Cap / Sales | 0 | 0 | 0.4 | 0.41 |
| Growth Ratio | ||||
| Net Sales Growth(%) | 0 | 0 | 53.93 | -22.56 |
| Core EBITDA Growth(%) | 0 | 1904000 | 13.52 | -25.84 |
| EBIT Growth(%) | 0 | 1591100 | 10.38 | -36.89 |
| PAT Growth(%) | 0 | 1019000 | 8.57 | -58.15 |
| EPS Growth(%) | 0 | 1019000 | 8.57 | -58.15 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 0.51 | 0.94 | 0.81 | 1.03 |
| Current Ratio(x) | 1.46 | 1.27 | 1.3 | 1.19 |
| Quick Ratio(x) | 0.3 | 0.19 | 0.37 | 0.17 |
| Interest Cover(x) | 0 | 5.28 | 4.3 | 2.44 |
| Total Debt/Mcap(x) | 0 | 0 | 0.84 | 1.37 |
FINANCIAL RATIOS (STANDALONE) FOR DHAMPUR BIO ORGANICS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | -0 | 15.61 | 16.87 | 7.35 |
| CEPS(Rs) | -0 | 20.24 | 22.95 | 14.8 |
| DPS(Rs) | 0 | 0 | 3.5 | 2.5 |
| Book NAV/Share(Rs) | 117.63 | 133.28 | 149.98 | 153.74 |
| Tax Rate(%) | 0 | 19.87 | 17.5 | 26.99 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 0 | 12.13 | 7.68 | 5.84 |
| EBIT Margin(%) | 0 | 10.34 | 6.66 | 4.75 |
| Pre Tax Margin(%) | 0 | 8.39 | 5.13 | 2.83 |
| PAT Margin (%) | 0 | 6.72 | 4.23 | 2.07 |
| Cash Profit Margin (%) | 0 | 8.72 | 5.75 | 4.16 |
| Performance Ratios | ||||
| ROA(%) | -0 | 5.82 | 5.43 | 2.21 |
| ROE(%) | -0 | 12.44 | 11.91 | 4.84 |
| ROCE(%) | -0 | 11.06 | 10.05 | 5.8 |
| Asset Turnover(x) | 0 | 0.87 | 1.28 | 1.07 |
| Sales/Fixed Asset(x) | 0 | 1.38 | 2.08 | 1.6 |
| Working Capital/Sales(x) | 0 | 5.95 | 11.1 | 13.69 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 0 | 0.73 | 0.48 | 0.63 |
| Receivable days | 0 | 25.25 | 16.62 | 17.06 |
| Inventory Days | 0 | 210.11 | 129.26 | 147 |
| Payable days | 0 | 73.31 | 33.05 | 40.96 |
| Valuation Parameters | ||||
| PER(x) | 0 | 0 | 8.49 | 15.63 |
| PCE(x) | 0 | 0 | 6.25 | 7.77 |
| Price/Book(x) | 0 | 0 | 0.96 | 0.75 |
| Yield(%) | 0 | 0 | 2.44 | 2.17 |
| EV/Net Sales(x) | 0 | 0.56 | 0.69 | 0.98 |
| EV/Core EBITDA(x) | -45979 | 4.47 | 7.76 | 11.16 |
| EV/EBIT(x) | -45979 | 5.45 | 9.36 | 16.08 |
| EV/CE(x) | 0.3 | 0.43 | 0.79 | 0.87 |
| M Cap / Sales | 0 | 0 | 0.4 | 0.42 |
| Growth Ratio | ||||
| Net Sales Growth(%) | 0 | 0 | 53.55 | -23.75 |
| Core EBITDA Growth(%) | 0 | 1942100 | 9.63 | -24.1 |
| EBIT Growth(%) | 0 | 1594100 | 10.74 | -36.47 |
| PAT Growth(%) | 0 | 1036200 | 7.66 | -56.42 |
| EPS Growth(%) | 0 | 1036200 | 7.66 | -56.42 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 0.51 | 0.93 | 0.81 | 1.03 |
| Current Ratio(x) | 1.45 | 1.26 | 1.27 | 1.16 |
| Quick Ratio(x) | 0.27 | 0.19 | 0.34 | 0.14 |
| Interest Cover(x) | 0 | 5.3 | 4.33 | 2.48 |
| Total Debt/Mcap(x) | 0 | 0 | 0.84 | 1.37 |
SHARE HOLDING PATTERN FOR DHAMPUR BIO ORGANICS LIMITED
| Date | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters % | 48.97 | 48.97 | 50.10 | 50.10 | 50.33 | 50.33 | 50.51 | 50.66 | 50.66 | 50.66 |
| FII % | 8.55 | 7.37 | 6.63 | 5.34 | 4.81 | 4.83 | 3.42 | 1.95 | 1.26 | 0.83 |
| DII % | 0.03 | 0.13 | 0.04 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.90 |
| Public % | 41.88 | 42.96 | 42.67 | 43.98 | 44.30 | 44.27 | 45.50 | 46.81 | 47.51 | 47.03 |
PEER COMPARISON FOR DHAMPUR BIO ORGANICS LIMITED
CORPORATE ACTIONS FOR DHAMPUR BIO
| Exchange Date | Purpose | Book Closure Dates |
|---|---|---|
| NSE 28-Jun-2024 | DIV - RS 2.50 PER SH | |
| NSE 23-Jun-2023 | DIV - RS 3.50 PER SH | |
CORPORATE ANNOUNCEMENTS FOR DHAMPUR BIO
| Exchange Date | Category File | Description |
|---|
INSIDER TRADING FOR DHAMPUR BIO
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 27-Mar-2024 27-Mar-2024 | Buy Market | 50,000 @ 0.00 (0.08 %) | Shudh Edible Products Pvt Ltd |
| BSE 26-Mar-2024 26-Mar-2024 | Buy Market | 40,000 @ 0.00 (0.06 %) | Shudh Edible Products Pvt Ltd |
| BSE 14-Mar-2024 14-Mar-2024 | Buy Market | 10,000 @ 0.00 (0.01 %) | Shudh Edible Products Pvt Ltd |
| BSE 26-Oct-2023 26-Oct-2023 | Buy Market | 5,136 @ 0.00 (0.01 %) | Sonitron Ltd |
| BSE 23-Oct-2023 23-Oct-2023 | Buy Market | 25,000 @ 0.00 (0.04 %) | Sonitron Ltd |
| BSE 25-Oct-2023 25-Oct-2023 | Buy Market | 19,864 @ 0.00 (0.03 %) | Sonitron Ltd |
| BSE 22-Mar-2023 22-Mar-2023 | Sell Market | 125,000 @ 0.00 (0.00 %) | Ujjwal Rural Services Ltd |
| BSE 22-Mar-2023 22-Mar-2023 | Sell Gift | 2,177,810 @ 0.00 (0.00 %) | Ashok Kumar Goel |
| BSE 22-Mar-2023 22-Mar-2023 | Buy Gift | 2,177,810 @ 0.00 (3.28 %) | Deepa Goel |
| BSE 22-Mar-2023 22-Mar-2023 | Sell Gift | 25,050 @ 0.00 (0.00 %) | Vinita Goel |
| BSE 22-Mar-2023 22-Mar-2023 | Sell Market | 1,166,760 @ 0.00 (0.00 %) | Saraswati Properties Ltd |
| BSE 22-Mar-2023 22-Mar-2023 | Buy Gift | 25,050 @ 0.00 (0.04 %) | Deepa Goel |
| BSE 22-Mar-2023 22-Mar-2023 | Buy Market | 1,166,760 @ 0.00 (1.76 %) | Deepa Goel |
| BSE 22-Mar-2023 22-Mar-2023 | Buy Market | 125,000 @ 0.00 (0.19 %) | Deepa Goel |
BULK BLOCK DEALS FOR DHAMPUR BIO ORGANICS LIMITED
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 22-Mar-2023 | Buy BULK | 1,166,758 @ 132.00 | DEEPA GOEL |
| BSE 22-Mar-2023 | Sell BULK | 1,166,758 @ 132.00 | SARASWATI PROPERTIES LIMITED |
| BSE 22-Mar-2023 | Buy BLOCK | 1,166,758 @ 132.00 | DEEPA GOEL |
| BSE 22-Mar-2023 | Sell BLOCK | 1,166,758 @ 132.00 | SARASWATI PROPERTIES LIMITED |
DIVIDEND BY DHAMPUR BIO ORGANICS LIMITED
| Ex Dividend Date | Dividend Type | Dividend |
|---|---|---|
| 28-Jun-2024 | DIVIDEND | 2.5 |
| 23-Jun-2023 | DIVIDEND | 3.5 |
SPLIT / BONUS BY DHAMPUR BIO ORGANICS LIMITED
No Split / Bonus details found
Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed